Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Sep 2017
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic retinopathy
- Focus Adverse reactions; Therapeutic Use
- Acronyms RECOVERY
- 21 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 29 Aug 2016 Status changed from not yet recruiting to recruiting.
- 18 Aug 2016 New trial record